Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients

NCT00663975 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Study not being conducted

Conditions

Digestive System Diseases
Pancreatic Disease
Cystic Fibrosis
Exocrine Pancreatic Insufficiency

Interventions

DRUG: DCI 1020

Sponsor

Digestive Care, Inc.